Ardent Health (ARDT) Cost of Revenue (2023 - 2026)

Ardent Health's Cost of Revenue history runs 4 years deep, the most recent figure standing at $268.6 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 3.75% year-over-year to $268.6 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 30.63% YoY), while the FY2025 annual figure was $1.1 billion, up 118.23% from the prior year.
• Cost of Revenue for Q1 2026 stood at $268.6 million, down from $277.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $651.4 million in Q4 2023, with the low at $108.8 million in Q2 2023.
• The 4-year median for Cost of Revenue is $254.2 million (2023), against an average of $243.7 million.
• Peak annual rise in Cost of Revenue reached 138.35% in 2024, while the deepest fall reached 78.3% in 2024.
• Ardent Health's Cost of Revenue stood at $651.4 million in 2023, then plunged by 78.3% to $141.4 million in 2024, then surged by 96.32% to $277.5 million in 2025, then fell by 3.24% to $268.6 million in 2026.
• Business Quant data shows ARDT's Cost of Revenue at $268.6 million in Q1 2026, $277.5 million in Q4 2025, and $198.7 million in Q3 2025.